J. Goldman & Co »

Neurocrine Biosciences shares owned by J. Goldman & Co

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by J. Goldman & Co from 13F filings

Historical chart of J. Goldman & Co investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by J. Goldman & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.1M 39k 131.76
2023-09-30 $11M 97k 112.50
2023-06-30 $12M 125k 94.30
2023-03-31 $883k 8.7k 101.22
2022-09-30 $4.8M 45k 106.20
2022-06-30 $739k 7.6k 97.47
2022-03-31 $638k 6.8k 93.82
2017-03-31 $2.0M 47k 43.30